hsg logo white

PodcastsEpisode 2 – Joseph Higgins

In our second episode, HD Insights Podcast welcomed Dr. Joseph Higgins, Vice President, Clinical Development, CNS at uniQure. Over the past summer, uniQure announced in a formal letter to the community that enrollment in the first clinical trial for AMT-130 was starting. We spoke with Dr. Higgins about the development effort around this novel treatment for Huntington’s disease, the reaction from the HD community, and his early career experiences in clinical research. Dr. Higgins shares some interesting stories about being activated for wartime duty while and the NIH, and a personal connection he has to George Huntington, the man who discovered and for whom HD is named after.